Osteochondral graft delivery device and uses thereof

Information

  • Patent Grant
  • 8753406
  • Patent Number
    8,753,406
  • Date Filed
    Tuesday, April 2, 2013
    11 years ago
  • Date Issued
    Tuesday, June 17, 2014
    10 years ago
Abstract
A delivery device for an osteochondral graft comprising a tube, a plunger and a graft retention assembly is disclosed. The tube has a bore having an inside diameter and extends from a proximal end to a distal end. The inside diameter of the bore is sufficient to accept an osteochondral graft of a desired diameter. The tube has a set of apertures located adjacent the distal end of the tube. The plunger is slidably disposed within the bore of the tube. The graft retention assembly comprises a collar and a set of tabs. The graft retention assembly is attached to the tube such that the tabs are disposed within the apertures of the tube. The tabs are biased towards each other but are capable of being displaced away from each other to receive or release the osteochondral graft.
Description
BACKGROUND

The present invention relates to instrumentation used in implantation of an osteochondral graft, more particularly, to a delivery device used in inserting the osteochondral graft in a previously prepared hole. The invention also relates to the use of the delivery device to implant an osteochondral graft.


The delivery device of the present invention can also be used or adapted for use with bone-only or cartilage-only grafts or grafts of other construction, including artificial grafts, such as non-tissue grafts made from metals and synthetic materials. The invention has particular utility in repairing localized damage to bone and cartilage, such as lesions and other defects in an articular surface of the knee or other weight-articulating joints.


The knee and other articulating joints are susceptible to lesions and other defects. These may be the result of injuries caused by friction between opposing bone surfaces. While treatment options for these injuries lie along a continuum of care culminating in joint replacement, one treatment option is to replace the osteochondral tissue at the site of the injury with a graft of healthy tissue. Typically, autografts or allografts are employed; however, xenografts and artificial grafts, as previously described, may be employed. The surgery to implant these grafts often can be conducted arthroscopically. For this and other reasons, graft implantation may be more desirable than joint replacement.


The procedure for implanting osteochondral grafts involves creating a recipient site by removing the localized defect. Typically, this is done by forming a hole of a desired diameter (or holes, potentially, depending on the size of the defect) at the site of the damage. The hole may be bored, punched, or curetted, etc. The excised hole is then filled with a replacement osteochondral graft having a diameter corresponding to the diameter of the hole. The typical graft is cylindrical in shape and consists of a layer of cartilage over a layer of bone. Depending on the size of the damage, multiple holes of the same or different diameters may be bored and filled. Generally, in such instances, one hole will be bored and then filled before an adjacent or even overlapping hole is bored and filled.


Varied instrumentation is required throughout the surgery, both for forming the hole and implanting the replacement graft. Certain instrumentation may be tailored to the specific implant diameter.


Due to the delicate nature of the implantation procedure, in that its ultimate purpose is to repair or replace the articular surface and restore normal function to the joint, the method by which the transplanted osteochondral graft is handled and introduced into the recipient site is of particular importance. A desirable delivery device would provide a means for securely holding onto the osteochondral graft so that it is not displaced from the delivery device prematurely while simultaneously avoiding damage to the osteochondral graft.


SUMMARY

The present invention relates to instrumentation used in implantation of an osteochondral graft, more particularly, to a delivery device used in inserting the osteochondral graft in a previously prepared hole. The invention also relates to the use of the delivery device to implant an osteochondral graft.


The delivery device of the present invention can also be used or adapted for use with bone-only or cartilage-only grafts or grafts of other construction, including artificial grafts, such as non-tissue grafts made from metals and synthetic materials. The invention has particular utility in repairing localized damage to bone and cartilage, such as lesions and other defects in an articular surface of the knee or other weight-articulating joints.


According to one aspect of the invention, there is provided a delivery device for an osteochondral graft. The delivery device has a tube, a plunger and a graft retention assembly. The tube comprises a bore, having an inside diameter, that extends from a proximal end to a distal end. The inside diameter of the bore is sufficient to accept an osteochondral graft of a desired diameter. A set of apertures are located adjacent the distal end of the tube. The plunger, slidably disposed within the bore of the tube, comprises a shaft having a proximal end, distal end, and distal tip. The graft retention assembly comprises a collar and a set of tabs, which are disposed within the apertures of the tube. The tabs are biased towards each other but are capable of being displaced away from each other to receive or release the osteochondral graft. The graft retention assembly may be attached to the tube at an annular recess located along an outside diameter of the tube proximal to the apertures by means of the collar.


The delivery device may further comprise a handle positioned at the proximal end of the tube, with the handle comprising a bore extending from a proximal end to a distal end, and the bore having an inside diameter at its distal end sufficient to accept an outside diameter of the proximal end of the tube. The handle may further comprise an annular recess located at the proximal end of its bore that can accommodate a pliable material providing frictional engagement with the shaft of the plunger.


In accordance with another aspect of the present invention, there is also provided a delivery device for an osteochondral graft comprising a tube, a plunger, a graft retention assembly, and a handle. The tube comprises a bore, having an inside diameter, that extends from a proximal end to a distal end. The inside diameter of bore is sufficient to accept an osteochondral graft of a desired diameter. A set of apertures are located adjacent the distal end of the tube, and an annular recess is located along an outside diameter of the tube proximal to the apertures.


The plunger, slidably disposed within the bore of the tube, comprises a shaft having a proximal end, distal end, and distal tip. The plunger has a handle positioned at its proximal end. The plunger also has a stepped-down section of reduced relative diameter located proximal to the distal tip of the plunger shaft.


The graft retention assembly comprises a collar and a set of tabs, which are disposed within the apertures of the tube. The tabs are biased towards each other but are capable of being displaced away from each other to receive or release the osteochondral graft. The graft retention assembly is attached to the tube at the annular recess by means of the collar. Movement of the shaft of the plunger distally within the tube causes the tabs of the graft retention assembly to be displaced away from each other.


The handle, positioned at the proximal end of the tube, comprises a bore extending from a proximal end to a distal end. The bore has an inside diameter at its distal end sufficient to accept an outside diameter of the proximal end of the tube. The handle also has an annular recess located at the proximal end of its bore that can accommodate a pliable material providing frictional engagement with the shaft of the plunger.


In accordance with another aspect of the present invention, there is provided a method of implanting an osteochondral graft to a recipient site using a delivery device of the present invention. The method comprises loading the osteochondral graft into the device by inserting the distal tip of the plunger into the proximal end of the tube, moving the plunger distally in the bore of the tube until the distal tip of the plunger engages the first protrusion causing the tabs of the graft retention assembly to be displaced away from each other, and inserting the osteochondral graft into the distal end of the tube. The plunger is then moved distally in the bore of the tube further until the first protrusion no longer engages the distal tip of the plunger and the first protrusion engages the stepped-down section of the plunger, causing the tabs of the graft retention assembly to move inwardly and come in contact with and secure the osteochondral graft. To implant the osteochondral graft, the delivery device with an adjacent osteochondral graft is positioned adjacent the recipient site. The osteochondral graft is delivered by moving the plunger distally in the bore of the tube further to extrude the osteochondral graft from the delivery device.


The features and advantages of the present invention will be readily apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.





BRIEF DESCRIPTION OF THE DRAWINGS

These drawings illustrate certain aspects of some of the embodiments of the present invention, and should not be used to limit or define the invention.



FIG. 1 is an elevational view of a delivery device of the present invention with plunger inserted.



FIG. 2 is a cross-sectional view of the delivery device and plunger of FIG. 1.



FIG. 3 is an elevational view of a plunger of the present invention.



FIG. 4 is a cross-sectional view of the plunger of FIG. 3.



FIG. 5 is a cross-sectional view of the tube portion of a delivery device of the present invention.



FIG. 6 is an elevational view of a spring tab assembly of the present invention.



FIG. 7 is an elevational view of the spring tab assembly of FIG. 6 from a different angle.



FIG. 8 is a cross-sectional view of the spring tab assembly of FIG. 7.



FIG. 9 is an elevational view of a handle of the present invention.



FIG. 10 is a cross-sectional view of the handle of FIG. 9.



FIG. 11 is an elevational view of a delivery device of the present invention without a spring tab assembly.





DESCRIPTION OF PREFERRED EMBODIMENTS

The present invention relates to instrumentation used in implantation of an osteochondral graft, more particularly, to a delivery device used in inserting the osteochondral graft in a previously prepared hole. The invention also relates to the use of the delivery device to implant an osteochondral graft. The invention has particular utility in repairing localized damage to bone and cartilage, such as lesions and other defects in an articular surface of the knee or other weight-articulating joints.


The delivery device of the present invention can be used for the implantation of grafts from various locations and sources. The delivery device of the present invention can be used or adapted for use with osteochondral grafts, bone-only grafts, or cartilage-only grafts, as well as grafts of other construction, including artificial grafts, such as non-tissue grafts made from metals and synthetic materials. Similarly, the device of the present invention can be used or adapted for use with autografts, allografts, and xenografts. The preferred use of the delivery device is for the implantation of osteochondral allografts.


The delivery device of the present invention provides a means for securely holding onto the osteochondral graft so that it is not displaced from the delivery device prematurely while simultaneously avoiding damage to the osteochondral graft.


In accordance with various embodiments of the present invention, the delivery device generally includes the following components: a tube, a plunger, a handle, and a graft retention assembly.


In the descriptions of these components that follow, various preferences for materials of construction are generally expressed. Typically, polymeric materials or stainless steel are employed. The use of other materials of construction for the components, beyond any expressed preferences, is within the scope of the present invention. Generally, any materials of construction can be used for a component as long as the function of the component is not defeated and the material of construction is considered acceptable for a surgical environment.


Similarly, in the descriptions of the components that follow, various preferences regarding whether a component is transparent, translucent, or opaque may be expressed. Notwithstanding any such expressed preferences, the optical properties of a component may be varied as long as the function of the component is not defeated and the optical properties are considered acceptable for the intended surgical environment.


It is contemplated that the delivery device of the present invention may be fabricated in various sizes to accommodate osteochondral grafts of different diameters. In some embodiments, an indicator of the delivery device to be used with an osteochondral graft of a given diameter is provided. In particularly preferred embodiments, the indicator includes a marking in the form of color-coding associated with the delivery device corresponding to a particular osteochondral graft diameter. Preferably, any other instruments within a surgical set that are tailored for use with the same osteochondral graft diameter will have similar markings.


Referring generally to FIGS. 1, 2, 5 and 11, a delivery device 10 includes tube 30. Preferably, tube 30 is formed from a polymeric material. Preferably tube 30 is transparent or translucent. Tube 30 has a proximal end 31, a distal end 32, an outside diameter 23, and a bore 34 extending from proximal end 31 to distal end 32. Bore 34 has an inside diameter 25. The inside diameter 25 of bore 34, particularly at the distal 32 end of tube 30, is of sufficient size to accept insertion of the osteochondral graft intended for use in the surgery. Desirably, the inside diameter 25 of bore 34 at the distal 32 end of tube 30 is slightly larger, preferably around 0.5 mm larger, than the diameter of osteochondral graft.


The inside diameter 25 (corresponding to inside surface 35) of bore 34 is desirably constant from proximal end 31 to distal end 32. The outside diameter 23 (corresponding to outside surface 33) of tube 30 may also be substantially constant from proximal end 31 to distal end 32. However, in various embodiments, outside surface 33 of tube 30 may have an area of reduced diameter, such as in the form of an annular recess 37 or a step. Annular recess 37 is described further in the context of apertures 38 and graft retention assembly. In various embodiments, the outer surface 33 of tube 30 may taper down toward distal end 32, for example, to achieve an area of reduced wall thickness at the distal tip 36. In certain embodiments, a 1 mm wall thickness is preferred at distal tip 36.


Located on the distal end of tube 30, proximal to distal tip 36 (between distal tip 36 and annular recess 37, when present) are apertures 38 for accommodating descending tabs of the graft retention assembly. Preferably, a set of, preferably two, apertures 38 in the form of opposing cutout panes or windows are formed in the tube 30. In alternative embodiments, a single aperture may be employed. Preferably, apertures 38 terminate distally short of distal tip 36, such that distal tip 36 exists in the form of a continuous annular surface.


Referring generally to FIGS. 2, 3 and 4, delivery device 10 has a plunger 40. Plunger 40, preferably formed from a polymeric material, is slidably disposed within bore 34 of tube 30. Plunger 40 has a shaft 41 with a proximal end 42 and distal end 43. During use of the delivery device 10, it is the distal movement of plunger 40 that causes an inserted osteochondral graft to be displaced from the delivery device 10 and implanted into the previously excised hole.


Desirably, the diameter of shaft 41 at distal tip 44 of distal end 43 substantially corresponds to the diameter of osteochondral graft. Among other benefits, this correspondence in diameter minimizes the likelihood of damage to osteochondral graft. Proximal to distal tip 44, shaft 41 has a stepped-down section 45 with a diameter smaller than that of the diameter of shaft 41 at distal tip 44. As will be described further in the context of graft retention assembly, stepped-down section 45 facilitates interaction between shaft 41 and graft retention assembly. Preferably, chamfers are provided where sections of shaft 41 having different diameters meet. In various embodiments, distal tip 44 desirably has a mating surface 46 adapted to engage osteochondral graft that is concave. In such embodiments, the concavity is preferably about 1 mm. In other embodiments, the mating surface 46 may have no curvature or may be convex.


Desirably, plunger 40 has a plunger handle 47 positioned at the proximal end 42 of shaft 41 to provide a means for gripping and depressing plunger 40. In preferred embodiments, plunger handle 47 is in the form of an enlarged button or other shape that serves as a stop against further distal movement of plunger 40. The plunger handle 47 may have an impacting surface adapted for manual depressing of the plunger 40 or for the use of a surgical hammer, mallet, or other instrument in mechanically depressing the plunger 40. The length of the plunger 40 can be tailored to achieve a desired osteochondral graft insertion depth. For example, plunger 40 can be tailored such that when it is fully depressed, the distal tip 44 may be retracted from, flush with, or extend past distal tip 36 of tube 30. For example, in certain embodiments, it may be desirable for plunger 40, when fully depressed, to remain from about 1 mm to about 2 mm retracted from distal tip 36 of tube 30. In use, this results in an implanted osteochondral graft that is about 1 mm to about 2 mm proud in the recipient hole.


Referring generally to FIGS. 1, 9 and 10, a handle 50, preferably formed from a polymeric material, is desirably positioned at the proximal end 31 of tube 30 to provide a means for gripping delivery device 10. In certain embodiments, handle 50 is integral to tube 30. Preferably, handle 50 is a separate component that is assembled onto the proximal end 31 of tube 30. In such embodiments, handle 50 can be viewed as having a distal end 52, a proximal end 53, and a bore 54 extending from the distal end 52 to the proximal end 53. In such embodiments, the distal end 52 of handle 50 is adapted for connection to the proximal end 31 of tube 30. Preferably, the proximal end 31 of tube 30 and the distal end 52 of handle 50 are sized such that the distal end 52 of handle 50 fits over the proximal end 31 of tube 30. The connection can be by friction fit, which is desirable, and/or secured by adhesive. The connection may also be by screw fit or other means. A desirable shape for handle 50 is a T-shaped contoured handle, such as depicted in FIG. 9.


Referring generally to FIG. 2, in embodiments where handle 50 is a separate component, the bore 54 at the proximal end 53 of handle 50 is of a diameter sufficient to allow slidable passage of plunger 40. Preferably, the inside diameter of bore 54 (corresponding to the inside surface of bore 54) at the proximal end 53 of handle 50 substantially corresponds to the inside diameter of tube 30. In preferred embodiments, an annular recess 55 (an area of increased inside diameter) is located within bore 54 at the proximal end 53 of handle 50. A pliable material, preferably a polymer o-ring, is disposed within the annular recess 55 that provides frictional engagement with shaft 41 of plunger 40. The o-ring acts as a seal that, during use of the delivery device 10, reduces, and preferably precludes, fluid within the joint cavity from flowing up through tube 30 and out of proximal end 31 of delivery device 10.


The delivery device 10 also has a graft retention assembly adapted for attachment to tube 30. In various embodiments, such as depicted in FIGS. 6, 7 and 8, the graft retention assembly is a spring tab assembly 90. Spring tab assembly 90 has a collar 92 that is adapted for attachment to tube 30. Spring tab assembly 90 also has a set of opposing tabs 95, corresponding preferably in number to the number of apertures 38, extending distally from collar 92, and terminating in distal tips 96. Spring tab assembly 90 is attached to tube 30 such that the tabs 95 reside within cutout panes 38. The method by which collar 92 is attached to tube 30 is not generally limited. In preferred embodiments, collar 92 is attached at and resides in annular recess 37 of tube 30. In preferred embodiments, collar 92 has a transverse slot that allows snap-fit attachment of collar 92 to tube 30.


Tabs 95 are biased, i.e., bent, towards each other when in a relaxed state but are capable of being expanded outwardly to receive and release the osteochondral graft. Desirably, the tabs 95 are bent equally from the points where they connect to the collar 92. In preferred embodiments, the extent of the bending is such that the protrusions 98 are a distance apart which is between 50-100% of the given graft diameter. Once osteochondral graft is positioned between tabs 95 and the force causing tabs 95 to expand is removed, the tabs 95 will move towards each other once again, coming in contact with and securing osteochondral graft. Preferably, the pressure exerted by the tabs 95 on the osteochondral graft is such that the tabs 95 provide enough static friction with the osteochondral graft so that it is not able to exit the delivery device 10 without the aid of the plunger 40 or other means. However, the force exerted by the tabs 95 should also not damage the osteochondral graft.


The expansion of tabs 95 to accept osteochondral graft and the subsequent inward movement of tabs 95 to secure osteochondral graft is the result of movement of shaft 41 of plunger 40 distally within tube 30. To facilitate the outward and inward movement of tabs 95, an inward facing first protrusion 97 is positioned on one or more of tabs 95. Preferably, an inward facing first protrusion 97 is positioned on each of tabs 95. First protrusion 97 is positioned proximal to distal tip 96. Preferably, first protrusion 97 is positioned half-way along the length of tabs 95.


As plunger 40 is depressed, distal tip 44 of shaft 41 first comes in contact with first protrusion 97, causing expansion of tabs 95 and facilitating insertion of osteochondral graft without risk of damage. Once the osteochondral graft has been inserted, plunger 40 is depressed further so that the first protrusion 97 engages the reduced diameter region of stepped-down section 45. First protrusion 97, depending upon the extent of the bending of tabs 95, may or may not actually come into physical contact with the shaft 41 of plunger 40 within the stepped-down section 45. At this point, tabs 95 will move towards each other once again, coming in contact with and securing osteochondral graft. In use, osteochondral graft is desirably secured within delivery device 10 with some portion of the graft extending beyond distal tip 36 of tube 30. This facilitates implantation of osteochondral graft in the previously prepared hole. For a desirable osteochondral graft having a length of about 10 mm, the graft, inserted and secured in the delivery device, extends desirably from about 0.5 mm to about 2 mm beyond distal tip 36 of tube 30, preferably about 2 mm beyond distal tip 36 of tube 30.


Due to the need for inward and outward movement of opposing fingers 95, spring tab assembly 90, and particularly opposing fingers 95, is preferably formed from stainless steel and is heat set in a bent state with opposing fingers 95 biased towards each other. In alternative embodiments, spring-biased polymeric materials or other biocompatible metals with appropriate flexibility may be employed. Other shape-memory materials may be employed.


In preferred embodiments of delivery device 10, an inward facing second protrusion 98 is positioned at or in proximity to distal tip 96 of one or more of tabs 95. Preferably, an inward facing second protrusion 98 is positioned on each of tabs 95. Second protrusion 98 facilitates gripping of osteochondral graft and reduces the likelihood of damaging osteochondral graft. A radius edge is desirably applied to the edges of the second protrusion 98 to further reduce the likelihood of damaging osteochondral graft. Desirably, a radius edge is applied to all the edges of the spring tab assembly 90. In various embodiments, a radius edge of about 1 mm is desirably employed on all edges of the spring tab assembly 90.


Having described the components of the delivery device 10, its use for implanting an osteochondral graft in a previously prepared hole is readily apparent but is described now in greater detail.


The distal tip 44 of plunger 40 is inserted into the proximal end 31 of tube 30 and moved distally within tube 30 until distal tip 44 engages first protrusion 97 of spring clip assembly 90. This causes the outward expansion of tabs 95. With tabs 95 now spread apart, a osteochondral graft is inserted, cartilage end first, into the distal end 32 of tube 30. Desirably, the osteochondral graft is left extending, preferably from about 1 mm to 2 mm, beyond distal tip 36 of tube 30.


The plunger 40 is now depressed further until first protrusion 97 is no longer in contact with the larger diameter of distal tip 44 of plunger 40. With first protrusion 97 now engaged with the reduced diameter region of stepped-down section 45, tabs 95 move towards each other, with distal tip 96, including second protrusion 98, if present, of tabs 95 coming in contact with and securing the osteochondral graft.


The delivery device 10 and the osteochondral graft are now ready to be used to implant the osteochondral graft into the recipient site, i.e., previously-prepared hole. In various embodiments of the present invention, the delivery device 10 may be used with a cannulated delivery guide that has a bore with an inside diameter sized to accommodate slidable passage of the delivery device 10. The delivery guide will preferably be made of a polymeric material but other materials of construction are contemplated. Similarly, the delivery guide may be transparent, translucent, or opaque. The delivery guide may be used to retract soft tissues (e.g., the naturally occurring fat pad) between the surgical incision or arthroscopic portal and the recipient site. In some embodiments, the delivery guide will generally be prepositioned over the prepared recipient site.


With or without the delivery guide, the delivery device 10 is positioned directly above, and preferably in contact with, the recipient site. The osteochondral graft is extruded from the delivery device 10 by depressing the plunger 40 until further distal movement of the plunger 40 is limited by the plunger handle 47, other stop, or complete insertion of the osteochondral graft in the recipient site. The delivery device 10 can then be removed from the surgical site. If the osteochondral graft remains proud, a tamp or other instrument can be used to further insert the osteochondral graft such that it is flush with the surrounding articular cartilage.


The delivery device 10 may be provided to a surgeon pre-assembled in its entirety. Alternatively, the component parts or some less-than-complete assemblage of the components parts may be provided for final assembly at some point prior to its use in implanting the osteochondral graft. For example, as provided to the surgeon, the plunger 40 may not already be inserted into tube 30.


Assembly of the delivery device 10 is readily straightforward and apparent to one of ordinary skill in the art having the benefit of this disclosure. In accordance with various embodiments described herein, handle 50, if not integral with tube 30, is attached to the proximal end 31 of tube 30. O-ring is placed within the annular recess 55 disposed in the inner surface of the proximal end 53 of the bore 54 of the handle 50. Spring tab assembly 90 is attached to the tube 30 such that tabs 95 reside in apertures 38. The distal tip 44 of plunger 40 is inserted into the proximal end 31 of tube 30 (initially through the proximal end of handle 50 if the handle 50 is not integral with tube 30).


Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. For example, while the primary intended use of the delivery device of the present invention is for use in implanting osteochondral grafts, it is envisioned that the delivery device could be used for implanting other tissue implants. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. The indefinite articles “a” or “an”, as used in the claims, are defined herein to mean one or more than one of the element that it introduces.

Claims
  • 1. An implant delivery device, comprising: a tube including a bore;a plunger disposed within the bore; andan implant retention assembly including a collar coupled to the tube, a first element protruding into the bore through an aperture in the tube, and a second element protruding into the bore through the aperture in the tube, the first element and the second element defining portions of a tab member that extends from the collar and toward the aperture in the tube, wherein contact between the plunger and the first element displaces the second element to permit receipt or release of an implant from the bore.
  • 2. The implant delivery device of claim 1, wherein the first element is a first protrusion extending from an inner surface of the tab member into the bore and the second element is a second protrusion extending from the inner surface of the tab member into the bore.
  • 3. The implant delivery device of claim 2, wherein the second protrusion is located adjacent to a distal tip of the tab member.
  • 4. The implant delivery device of claim 1, wherein the implant retention assembly is a spring tab assembly.
  • 5. A delivery device for an implant, comprising: a tube including a bore extending from a proximal end to a distal end of the tube, wherein an inner dimension of the bore is sufficient to accept an implant of a desired size, and at least one aperture located adjacent the distal end of the tube;a plunger slidably disposed within the bore of the tube and including a shaft having a proximal end and a distal end; andan implant retention assembly including a collar coupled to the tube and at least one tab, at least a portion of the at least one tab configured to be disposed within the at least one aperture of the tube, wherein the at least one tab is biased inwardly toward a center region of the bore but is capable of being displaced outwardly to receive or release the implant.
  • 6. The delivery device of claim 5, wherein the at least one tab includes a first tab and a second tab, and wherein the at least one aperture includes a first aperture and a second aperture.
  • 7. The delivery device of claim 6, further comprising a first inwardly facing protrusion on the first tab and a second inwardly facing protrusion on the second tab, wherein the first and second tabs are configured to be displaced outwardly to receive or release the implant when the first and second inwardly facing protrusions are contacted by the distal end of the shaft.
  • 8. The delivery device of claim 5, wherein the collar of the retention assembly is at least partially disposed within a recess in the outer surface of the tube.
  • 9. The delivery device of claim 5, wherein a distal tip of the at least one tab includes a retention member configured for retaining the implant within the bore of the tube.
  • 10. The delivery device of claim 5, further comprising a pliable member positioned within the bore of the tube and configured for providing frictional engagement with the shaft of the plunger.
  • 11. An implant delivery device, comprising: a tube including a bore;a plunger disposed within the bore; andan implant retention assembly including a first element protruding into the bore through a first aperture in the tube, a second element protruding into the bore through the first aperture in the tube, a third element protruding into the bore through a second aperture in the tube, and a fourth element protruding into the bore through the second aperture in the tube, the first element and the second element defining portions of a first tab member, and the third element and the fourth element defining portions of a second tab member, wherein the first and second tab members extend from a collar coupled to the tube, and wherein movement of a shaft of the plunger within the tube causes the first and second tab members to be displaced away from each other, with contact between the plunger and the first and third elements displacing the second and fourth elements, respectively, to permit receipt of an implant from the bore.
Parent Case Info

This application is a continuation of and claims the benefit of priority of U.S. patent application Ser. No. 12/873,049, filed on Aug. 31, 2010, which is hereby incorporated by reference herein in its entirety.

US Referenced Citations (421)
Number Name Date Kind
493730 McKenzie Mar 1893 A
1405720 Scott Feb 1922 A
1567910 Franz et al. Dec 1925 A
1703154 Lanzkron Feb 1929 A
1984839 Murray Dec 1934 A
2573462 Earle Oct 1951 A
3564947 Maier Feb 1971 A
3564948 Pomernacki Feb 1971 A
3841909 Nonaka et al. Oct 1974 A
3848601 Ma Nov 1974 A
3875595 Froning Apr 1975 A
3949743 Shanbrom Apr 1976 A
3971273 Peters et al. Jul 1976 A
4010737 Vilaghy et al. Mar 1977 A
4069216 Shanbrom Jan 1978 A
4086218 Shanbrom et al. Apr 1978 A
4105650 Shanbrom et al. Aug 1978 A
4137223 Shanbrom et al. Jan 1979 A
4142592 Brusselmans Mar 1979 A
4186448 Brekke Feb 1980 A
4188318 Shanbrom Feb 1980 A
4189425 Shanbrom et al. Feb 1980 A
4250892 Dolhay et al. Feb 1981 A
4277184 Solomon Jul 1981 A
4294753 Urist Oct 1981 A
4305871 Shanbrom Dec 1981 A
4314997 Shanbrom Feb 1982 A
4315919 Shanbrom Feb 1982 A
4378224 Nimni et al. Mar 1983 A
4387092 Liautaud et al. Jun 1983 A
4412985 Shanbrom Nov 1983 A
4465623 Chanas et al. Aug 1984 A
4571921 Wolfson Feb 1986 A
4589206 Marcoux May 1986 A
4627853 Campbell et al. Dec 1986 A
4645488 Matukas Feb 1987 A
4706659 Matthews et al. Nov 1987 A
4932973 Gendler Jun 1990 A
4933169 Shanbrom Jun 1990 A
4950256 Luther et al. Aug 1990 A
4997915 Tan et al. Mar 1991 A
5002583 Pitaru et al. Mar 1991 A
5019495 Shanbrom May 1991 A
5067964 Richmond et al. Nov 1991 A
5112354 Sires May 1992 A
5115704 Hyman May 1992 A
5128149 Shanbrom Jul 1992 A
5128150 Shanbrom Jul 1992 A
5139520 Rosenberg Aug 1992 A
5152763 Johnson Oct 1992 A
5152791 Hakamatsuka et al. Oct 1992 A
5156973 Shanbrom Oct 1992 A
5160313 Carpenter et al. Nov 1992 A
5165824 Corcoran et al. Nov 1992 A
5184926 Hemmings Feb 1993 A
5186945 Shanbrom Feb 1993 A
5197833 Mayer et al. Mar 1993 A
5204324 Shanbrom Apr 1993 A
5207681 Ghadjar et al. May 1993 A
5211661 Shinjou et al. May 1993 A
5259971 Smith Morse et al. Nov 1993 A
5320115 Kenna Jun 1994 A
5320626 Schmieding Jun 1994 A
5328722 Ghanayem et al. Jul 1994 A
5333626 Morse et al. Aug 1994 A
5341816 Allen Aug 1994 A
5345927 Bonutti Sep 1994 A
5360605 Shanbrom Nov 1994 A
5362166 Yamamoto et al. Nov 1994 A
5368051 Dunn et al. Nov 1994 A
5370692 Fink et al. Dec 1994 A
5370869 Shanbrom Dec 1994 A
5374539 Nimni et al. Dec 1994 A
5423823 Schmieding Jun 1995 A
5425490 Goble et al. Jun 1995 A
5443468 Johnson Aug 1995 A
5496326 Johnson Mar 1996 A
5513662 Morse et al. May 1996 A
5545401 Shanbrom Aug 1996 A
5556379 Wolfinbarger Sep 1996 A
5575798 Koutrouvelis Nov 1996 A
5587912 Andersson et al. Dec 1996 A
5589072 Shanbrom Dec 1996 A
5591234 Kirsch Jan 1997 A
5603716 Morgan et al. Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5609864 Shanbrom Mar 1997 A
5613982 Goldstein Mar 1997 A
5632745 Schwartz May 1997 A
5632747 Scarborough et al. May 1997 A
5632778 Goldstein May 1997 A
5697932 Smith et al. Dec 1997 A
5716413 Walter Feb 1998 A
5718707 Mikhail Feb 1998 A
5741685 Vacanti Apr 1998 A
5741782 Brockbank et al. Apr 1998 A
5769899 Schwartz et al. Jun 1998 A
5770705 Shanbrom Jun 1998 A
5771310 Vannah Jun 1998 A
5782835 Hart et al. Jul 1998 A
5782915 Stone Jul 1998 A
5785522 Bergstrom et al. Jul 1998 A
5788713 Dubach et al. Aug 1998 A
5797871 Wolfinbarger, Jr. Aug 1998 A
5800537 Bell Sep 1998 A
5810887 Accorti, Jr. et al. Sep 1998 A
5811471 Shanbrom Sep 1998 A
5814225 Shanbrom Sep 1998 A
5817153 Pendl et al. Oct 1998 A
5820581 Wolfinbarger, Jr. Oct 1998 A
5843182 Goldstein Dec 1998 A
5853746 Hunziker Dec 1998 A
5854397 Mechanic Dec 1998 A
5858641 Shanbrom Jan 1999 A
5860946 Hofstatter Jan 1999 A
5865803 Major Feb 1999 A
5865849 Stone Feb 1999 A
5876452 Athanasiou et al. Mar 1999 A
5881733 Stone Mar 1999 A
5885293 Mcdevitt et al. Mar 1999 A
5888061 Reynolds Mar 1999 A
5899860 Pfeiffer et al. May 1999 A
5899936 Goldstein May 1999 A
5902338 Stone May 1999 A
5904717 Brekke et al. May 1999 A
5916265 Ju Jun 1999 A
5919196 Bobic et al. Jul 1999 A
5919907 Shanbrom Jul 1999 A
5921987 Stone Jul 1999 A
5922027 Stone Jul 1999 A
5944755 Stone Aug 1999 A
5976104 Wolfinbarger, Jr. Nov 1999 A
5977432 Wolfinbarger, Jr. et al. Nov 1999 A
5984858 Stone Nov 1999 A
5985260 Shanbrom Nov 1999 A
5993451 Burkhart Nov 1999 A
5993844 Abraham et al. Nov 1999 A
6013853 Athanasiou et al. Jan 2000 A
6017348 Hart et al. Jan 2000 A
6017349 Heller et al. Jan 2000 A
6019765 Thornhill et al. Feb 2000 A
6024735 Wolfinbarger, Jr. Feb 2000 A
6025538 Yaccarino, III Feb 2000 A
6027743 Khouri et al. Feb 2000 A
6036738 Chanbrom Mar 2000 A
6045787 Shanbrom Apr 2000 A
6046379 Stone et al. Apr 2000 A
6049025 Stone Apr 2000 A
6063088 Winslow May 2000 A
6063210 Chakrabarti et al. May 2000 A
6074394 Krause Jun 2000 A
6090998 Grooms et al. Jul 2000 A
6093204 Stone Jul 2000 A
6093401 Shanbrom Jul 2000 A
6096216 Shanbrom et al. Aug 2000 A
6110178 Zech et al. Aug 2000 A
6110206 Stone Aug 2000 A
6110482 Khouri et al. Aug 2000 A
6123731 Boyce et al. Sep 2000 A
6146385 Torrie et al. Nov 2000 A
6179871 Halpern Jan 2001 B1
6183764 Shanbrom Feb 2001 B1
6193722 Zech et al. Feb 2001 B1
6210440 Stone et al. Apr 2001 B1
6224574 Al-Labban May 2001 B1
6231608 Stone May 2001 B1
6235035 Boukhris May 2001 B1
6242247 Reiser et al. Jun 2001 B1
6251143 Schwartz et al. Jun 2001 B1
6267786 Stone Jul 2001 B1
6270503 Schmieding Aug 2001 B1
6302887 Spranza et al. Oct 2001 B1
6306142 Johanson et al. Oct 2001 B1
6322593 Pathak Nov 2001 B1
6350732 Moore et al. Feb 2002 B1
6358253 Torrie et al. Mar 2002 B1
6361786 Shanbrom Mar 2002 B1
6375658 Hangody et al. Apr 2002 B1
6382204 Jansen et al. May 2002 B1
6383732 Stone May 2002 B1
6395011 Johanson et al. May 2002 B1
6402783 Stone Jun 2002 B1
6440141 Philippon Aug 2002 B1
6448076 Dennis et al. Sep 2002 B2
6455309 Stone Sep 2002 B2
6459948 Ateshian et al. Oct 2002 B1
6468314 Schwartz et al. Oct 2002 B2
6488033 Cerundolo Dec 2002 B1
6511511 Slivka et al. Jan 2003 B1
6520964 Tallarida et al. Feb 2003 B2
6521179 Girardot et al. Feb 2003 B1
6530928 Frei et al. Mar 2003 B1
6541518 Shanbrom Apr 2003 B2
6548076 Shanbrom Apr 2003 B2
6569200 Wolfinbarger, Jr. et al. May 2003 B2
6582438 DeMayo Jun 2003 B2
6591581 Schmieding Jul 2003 B2
6592588 Bobic et al. Jul 2003 B1
6599690 Abraham et al. Jul 2003 B1
6610067 Tallarida et al. Aug 2003 B2
6610316 Shanbrom Aug 2003 B2
6626945 Simon et al. Sep 2003 B2
6626950 Brown et al. Sep 2003 B2
6632246 Simon et al. Oct 2003 B1
6652592 Grooms et al. Nov 2003 B1
6656195 Peters et al. Dec 2003 B2
6679917 Ek Jan 2004 B2
6682695 Macphee et al. Jan 2004 B2
6682760 Noff et al. Jan 2004 B2
6689161 Chen et al. Feb 2004 B2
6696270 Badylak et al. Feb 2004 B2
6699252 Farr, II et al. Mar 2004 B2
6727224 Zhang et al. Apr 2004 B1
6734018 Wolfinbarger et al. May 2004 B2
6743435 Devore et al. Jun 2004 B2
6743574 Wolfinbarger, Jr. et al. Jun 2004 B1
6758865 Stone et al. Jul 2004 B1
6767354 Johanson et al. Jul 2004 B2
6793429 Arrison Sep 2004 B2
6793676 Plouhar et al. Sep 2004 B2
6821533 Shanbrom Nov 2004 B2
6837907 Wolfinbarger, Jr. et al. Jan 2005 B2
6841060 Shanbrom Jan 2005 B2
6852114 Cerundolo Feb 2005 B2
6852125 Simon et al. Feb 2005 B2
6855169 Boyer et al. Feb 2005 B2
6858042 Nadler et al. Feb 2005 B2
6863905 Shanbrom Mar 2005 B1
6881731 Shanbrom Apr 2005 B1
6884245 Spranza, III Apr 2005 B2
6893653 Abraham et al. May 2005 B2
6933103 Klein et al. Aug 2005 B1
6972041 Stone Dec 2005 B1
6988015 Schopf et al. Jan 2006 B1
6998418 Sung et al. Feb 2006 B1
7008763 Cheung Mar 2006 B2
7029479 Tallarida et al. Apr 2006 B2
7037339 Houfburg May 2006 B2
7048477 Abrams May 2006 B2
7060022 Chen et al. Jun 2006 B2
7064187 Stone Jun 2006 B2
7129035 Goldstein et al. Oct 2006 B2
7160305 Schmieding Jan 2007 B2
7175979 Luwel et al. Feb 2007 B2
7217294 Kusanagi et al. May 2007 B2
7264634 Schmieding Sep 2007 B2
7291149 Michelson Nov 2007 B1
7297716 Shanbrom Nov 2007 B2
7323445 Zhang et al. Jan 2008 B2
7371260 Malinin May 2008 B2
7410947 Rueger et al. Aug 2008 B2
7411006 Shanbrom Aug 2008 B2
7416371 Scott et al. Aug 2008 B2
7427293 Nycz et al. Sep 2008 B2
RE40570 Carpentier et al. Nov 2008 E
7548865 Schmieding Jun 2009 B2
7550007 Malinin Jun 2009 B2
7563266 Camino et al. Jul 2009 B2
7572291 Gil et al. Aug 2009 B2
7591820 Schmieding et al. Sep 2009 B2
7608098 Stone Oct 2009 B1
7666230 Orban Feb 2010 B2
7758583 Gil et al. Jul 2010 B2
7758643 Stone et al. Jul 2010 B2
7776043 Hycz et al. Aug 2010 B2
7833269 Nycz et al. Nov 2010 B2
7862567 Schmieding Jan 2011 B2
7875032 Lyons Jan 2011 B2
7879040 Bharadwaj Feb 2011 B2
7887546 Gil Feb 2011 B2
7905904 Stone et al. Mar 2011 B2
7909851 Stone et al. Mar 2011 B2
7909873 Tan-Malecki et al. Mar 2011 B2
7914539 Stone et al. Mar 2011 B2
7955335 Gil et al. Jun 2011 B2
7955336 Gil et al. Jun 2011 B2
7985230 Gil et al. Jul 2011 B2
7997174 Gil et al. Aug 2011 B2
8034090 Stone et al. Oct 2011 B2
8048079 Iannarone Nov 2011 B2
RE43714 Nadler et al. Oct 2012 E
8435305 Lozier et al. May 2013 B2
20010000804 Goldstein et al. May 2001 A1
20010051828 Stone et al. Dec 2001 A1
20020013627 Geistlich et al. Jan 2002 A1
20020026244 Trieu Feb 2002 A1
20020082704 Cerundolo Jun 2002 A1
20020087211 Stone et al. Jul 2002 A1
20020102287 Shanbrom Aug 2002 A1
20020117403 Shanbrom Aug 2002 A1
20020119437 Grroms et al. Aug 2002 A1
20020127719 Stone Sep 2002 A1
20020191487 Sand Dec 2002 A1
20030012687 Macphee et al. Jan 2003 A1
20030022149 Shanbrom Jan 2003 A1
20030027125 Mills et al. Feb 2003 A1
20030035843 Livesey et al. Feb 2003 A1
20030036762 Kerr et al. Feb 2003 A1
20030036801 Schwartz et al. Feb 2003 A1
20030039673 Shanbrom Feb 2003 A1
20030064090 Khouri et al. Apr 2003 A1
20030065333 DeMayo Apr 2003 A1
20030068815 Stone et al. Apr 2003 A1
20030074065 Stone Apr 2003 A1
20030129167 Shanbrom Jul 2003 A1
20030135209 Seedhom et al. Jul 2003 A1
20030144743 Edwards et al. Jul 2003 A1
20030161897 Shanbrom Aug 2003 A1
20030167062 Gambale et al. Sep 2003 A1
20030171810 Steiner Sep 2003 A1
20030180181 Greib et al. Sep 2003 A1
20030198699 Shanbrom Oct 2003 A1
20030216669 Lang et al. Nov 2003 A1
20030220700 Hammer et al. Nov 2003 A1
20030225459 Hammer et al. Dec 2003 A1
20030228692 Goldstein et al. Dec 2003 A1
20030229400 Masuda et al. Dec 2003 A1
20040034359 Schmeiding et al. Feb 2004 A1
20040037735 Depaula et al. Feb 2004 A1
20040039400 Schmieding et al. Feb 2004 A1
20040048796 Hariri et al. Mar 2004 A1
20040052830 Konertz et al. Mar 2004 A1
20040059425 Schmieding Mar 2004 A1
20040059430 Kim et al. Mar 2004 A1
20040067582 Lloyd et al. Apr 2004 A1
20040073223 Burkinshaw Apr 2004 A1
20040076657 Wolfinbarger, Jr. et al. Apr 2004 A1
20040081954 Stone et al. Apr 2004 A1
20040098135 Stone et al. May 2004 A1
20040147932 Burkinshaw et al. Jul 2004 A1
20040157206 Fisher et al. Aug 2004 A1
20040176771 Schmieding Sep 2004 A1
20040192605 Zhang et al. Sep 2004 A1
20040193154 Leatherbury et al. Sep 2004 A1
20040197373 Gertzman et al. Oct 2004 A1
20040204715 Evans et al. Oct 2004 A1
20040230194 Urbanski et al. Nov 2004 A1
20040230303 Gomes et al. Nov 2004 A1
20040234507 Stoen Nov 2004 A1
20040236340 Cirotteau et al. Nov 2004 A1
20040243250 Stone et al. Dec 2004 A1
20050013870 Freyman et al. Jan 2005 A1
20050013872 Freyman Jan 2005 A1
20050021044 Stone et al. Jan 2005 A1
20050038520 Bienette et al. Feb 2005 A1
20050043813 Kusanagi Feb 2005 A1
20050043814 Kusanagi et al. Feb 2005 A1
20050043819 Schmidt et al. Feb 2005 A1
20050064042 Vunjak-novakovic et al. Mar 2005 A1
20050064591 Stone Mar 2005 A1
20050080435 Smith et al. Apr 2005 A1
20050089544 Khouri et al. Apr 2005 A1
20050113736 Orr et al. May 2005 A1
20050124997 Pajunk et al. Jun 2005 A1
20050137600 Jacobs et al. Jun 2005 A1
20050196393 Shanbrom Sep 2005 A1
20050209705 Niederauer et al. Sep 2005 A1
20050222687 Vunjak-novakovic et al. Oct 2005 A1
20050251268 Truncale Nov 2005 A1
20050256588 Sawa et al. Nov 2005 A1
20060019234 Shanbrom Jan 2006 A1
20060024380 Abraham et al. Feb 2006 A1
20060060209 Shepard Mar 2006 A1
20060083729 Kusanagi et al. Apr 2006 A1
20060127495 Cheung Jun 2006 A1
20060127876 Cheung Jun 2006 A1
20060131906 Maurer et al. Jun 2006 A1
20060142684 Shanbrom Jun 2006 A1
20060178748 Dinger, III et al. Aug 2006 A1
20060193885 Leonard Neethling et al. Aug 2006 A1
20060195188 O'Driscoll et al. Aug 2006 A1
20060247790 McKay Nov 2006 A1
20060275377 Gomes et al. Dec 2006 A1
20070010897 Stone Jan 2007 A1
20070043376 Leatherbury et al. Feb 2007 A1
20070093896 Malinin Apr 2007 A1
20070135917 Malinin Jun 2007 A1
20070135918 Malinin Jun 2007 A1
20070135928 Malinin Jun 2007 A1
20070149982 Lyons Jun 2007 A1
20070270711 Gil et al. Nov 2007 A1
20070276506 Troxel Nov 2007 A1
20070299517 Davisson Dec 2007 A1
20080019115 Park, II et al. Jan 2008 A1
20080027447 Gil et al. Jan 2008 A1
20080051812 Schmitz et al. Feb 2008 A1
20080058953 Scarborough Mar 2008 A1
20080167653 Watlington et al. Jul 2008 A1
20080195115 Oren et al. Aug 2008 A1
20080200915 Globerman et al. Aug 2008 A1
20080243028 Howard et al. Oct 2008 A1
20080243029 Howard et al. Oct 2008 A1
20080255427 Satake et al. Oct 2008 A1
20080262616 McKay Oct 2008 A1
20080269566 Measamer et al. Oct 2008 A1
20080281081 Shanbrom Nov 2008 A1
20080306608 Nycz et al. Dec 2008 A1
20090024224 Chen et al. Jan 2009 A1
20090047085 Liao et al. Feb 2009 A1
20090054906 Walthall et al. Feb 2009 A1
20090076556 McGarity et al. Mar 2009 A1
20090171359 Sterrett Jul 2009 A1
20090209962 Jamali Aug 2009 A1
20090228031 Ritter Sep 2009 A1
20090275950 Sterrett et al. Nov 2009 A1
20090281550 Keller Nov 2009 A1
20090299371 Steiner et al. Dec 2009 A1
20090299372 Steiner et al. Dec 2009 A1
20090319051 Nycz et al. Dec 2009 A9
20100123325 Maffeis May 2010 A1
20100168750 Sherman Jul 2010 A1
20100249786 Schmieding et al. Sep 2010 A1
20100292704 Stoffel et al. Nov 2010 A1
20110009872 Mistry et al. Jan 2011 A1
20110046628 Jamali Feb 2011 A1
20110054408 Wei et al. Mar 2011 A1
20110137315 Gil et al. Jun 2011 A1
20110144648 Gil et al. Jun 2011 A1
20110208193 Gil et al. Aug 2011 A1
20120053588 Lozier et al. Mar 2012 A1
20120053642 Lozier et al. Mar 2012 A1
Foreign Referenced Citations (98)
Number Date Country
4922296 Sep 1996 AU
700349 Jan 1997 AU
717552 Mar 1998 AU
2411618 Apr 1975 DE
2830566 Jan 1980 DE
2933174 Apr 1980 DE
4317448 Nov 1994 DE
19503504 Mar 1996 DE
0307241 Mar 1989 EP
0493698 Jul 1992 EP
0508710 Oct 1992 EP
0399647 Dec 1995 EP
0768332 Apr 1997 EP
0779320 Jun 1997 EP
0815809 Jan 1998 EP
0824893 Feb 1998 EP
0824893 Feb 1998 EP
0871414 Oct 1998 EP
0584195 Sep 2001 EP
1006957 May 2003 EP
0740555 Mar 2004 EP
0814710 Apr 2004 EP
1237511 Sep 2004 EP
1452150 Sep 2004 EP
1637037 Mar 2006 EP
1234552 Aug 2006 EP
1698358 Sep 2006 EP
2700462 Jul 1994 FR
2860423 Apr 2005 FR
1565340 Apr 1980 GB
2175506 Dec 1986 GB
3178652 Feb 1991 JP
4303450 Oct 1992 JP
9122226 May 1997 JP
10251492 Sep 1998 JP
10513386 Dec 1998 JP
2088240 Aug 1997 RU
WO-9106213 May 1991 WO
WO-9211046 Jul 1992 WO
WO-9212631 Aug 1992 WO
WO-9315694 Aug 1993 WO
WO-9426211 Nov 1994 WO
WO-9502350 Jan 1995 WO
WO-9612509 May 1996 WO
WO-9624302 Aug 1996 WO
WO-9624310 Aug 1996 WO
WO-9627333 Sep 1996 WO
WO-9634955 Nov 1996 WO
WO-9725942 Jul 1997 WO
WO-9746665 Dec 1997 WO
WO-9802578 Jan 1998 WO
WO-9834569 Aug 1998 WO
WO-9834596 Aug 1998 WO
WO-9840027 Sep 1998 WO
WO-9846165 Oct 1998 WO
WO-9856317 Dec 1998 WO
WO-9921497 May 1999 WO
WO-9947080 Sep 1999 WO
WO-9944533 Oct 1999 WO
WO-9951170 Oct 1999 WO
WO-0029037 May 2000 WO
WO-0041739 Jul 2000 WO
WO-0047131 Aug 2000 WO
WO-0047132 Aug 2000 WO
WO-0105336 Jan 2001 WO
WO-0108715 Feb 2001 WO
WO-0130276 May 2001 WO
WO-0143667 Jun 2001 WO
WO-0154619 Aug 2001 WO
WO-0182993 Nov 2001 WO
WO-0191671 Dec 2001 WO
WO-0224244 Mar 2002 WO
WO-02089711 Nov 2002 WO
WO-03023272 Mar 2003 WO
WO-03097809 Nov 2003 WO
WO-2004017731 Mar 2004 WO
WO-2004047622 Jun 2004 WO
WO-2004052098 Jun 2004 WO
WO-2004075727 Sep 2004 WO
WO-2004075940 Sep 2004 WO
WO-2004100841 Nov 2004 WO
WO-2004103224 Dec 2004 WO
WO-2005023321 Mar 2005 WO
WO-2005038016 Apr 2005 WO
WO-2005063314 Jul 2005 WO
WO-2005092208 Oct 2005 WO
WO-2005094694 Oct 2005 WO
WO-2005112627 Dec 2005 WO
WO-2005118014 Dec 2005 WO
WO-2006026325 Mar 2006 WO
WO-2006026325 Mar 2006 WO
WO-2006026981 Mar 2006 WO
WO-2006074373 Jul 2006 WO
WO-2006092718 Sep 2006 WO
WO-2008147692 Dec 2008 WO
WO-2009114524 Sep 2009 WO
WO-2010092100 Aug 2010 WO
WO-2011008968 Jan 2011 WO
Non-Patent Literature Citations (236)
Entry
“U.S. Appl. No. 10/149,853, Non Final Office Action mailed Apr. 13, 2004”, 7 pgs.
“U.S. Appl. No. 10/149,853, Notice of Allowance mailed Oct. 5, 2004”, 7 pgs.
“U.S. Appl. No. 10/149,853, Preliminary Amendment mailed Oct. 17, 2002”, 6 pgs.
“U.S. Appl. No. 10/149,853, Response filed Jul. 6, 2004 to Non Final Office Action mailed Apr. 13, 2004”, 9 pgs.
“U.S. Appl. No. 11/705,575, Non Final Office Action mailed Mar. 16, 2005”, 8 pgs.
“U.S. Appl. No. 11/705,575, Non Final Office Action mailed Sep. 15, 2011”, 7 pgs.
“U.S. Appl. No. 11/705,575, Notice of Allowance mailed May 15, 2012”, 5 pgs.
“U.S. Appl. No. 11/705,575, Notice of Non-Compliant Amendment mailed Jan. 7, 2011”, 3 pgs.
“U.S. Appl. No. 11/705,575, Notice of Non-Compliant Amendment mailed Oct. 29, 2010”, 3 pgs.
“U.S. Appl. No. 11/705,575, Preliminary Amendment filed Feb. 12, 2007”, 14 pgs.
“U.S. Appl. No. 11/705,575, Response filed Feb. 7, 2011 to Notice of Non-Compliant Amendment mailed Jan. 7, 2011”, 22 pgs.
“U.S. Appl. No. 11/705,575, Response filed Sep. 15, 2010 to Non Final Office Action mailed Mar. 16, 2010”, 13 pgs.
“U.S. Appl. No. 11/705,575, Response filed Nov. 29, 2010 to Notice of Non-Compliant Amendment mailed Oct. 29, 2010”, 14 pgs.
“U.S. Appl. No. 11/705,575, Response filed Dec. 15, 2011 to Non Final Office Action mailed Sep. 15, 2011”, 14 pgs.
“U.S. Appl. No. 11/705,575, Revised Preliminary Amendment filed Sep. 15, 2010 in Response to Office Action mailed Mar. 16, 2010”, 11 pgs.
“U.S. Appl. No. 11/753,102, Advisory Action filed Dec. 10, 2010”, 3 pgs.
“U.S. Appl. No. 11/753,102, Final Office Action mailed Aug. 3, 2010”, 14 pgs.
“U.S. Appl. No. 11/753,102, Non Final Office Action mailed Jan. 4, 2010”, 13 pgs.
“U.S. Appl. No. 11/753,102, Response filed May 4, 2010 to Non Final Office Action mailed Jan. 4, 2010”, 13 pgs.
“U.S. Appl. No. 11/753,102, Response filed Nov. 23, 2009 to Restriction Requirement mailed Oct. 30, 2009”, 12 pgs.
“U.S. Appl. No. 11/753,102, Response filed Dec. 3, 2010 to Final Office Action mailed Aug. 3, 2010”, 15 pgs.
“U.S. Appl. No. 11/753,102, Restriction Requirement mailed Oct. 30, 2009”, 9 pgs.
“U.S. Appl. No. 11/759,679, Final Office Action mailed Oct. 7, 2010”, 17 pgs.
“U.S. Appl. No. 11/759,679, Non Final Office Action mailed Feb. 26, 2010”, 14 pgs.
“U.S. Appl. No. 11/759,679, Response filed Jun. 28, 2009 to Non Final Office Action mailed Feb. 26, 2010”, 13 pgs.
“U.S. Appl. No. 11/759,679, Response filed Oct. 30, 2009 to Restriction Requirement mailed Sep. 4, 2009”, 3 pgs.
“U.S. Appl. No. 11/759,679, Restriction Requirement mailed Sep. 4, 2009”, 6 pgs.
“U.S. Appl. No. 12/045,416, Final Office Action mailed Feb. 27, 2012”, 13 pgs.
“U.S. Appl. No. 12/045,416, Non Final Office Action mailed Aug. 4, 2011”, 12 pgs.
“U.S. Appl. No. 12/045,416, Response filed Jun. 2, 2011 to Restriction Requirement mailed May 11, 2011”, 13 pgs.
“U.S. Appl. No. 12/045,416, Response filed Jul. 17, 2012 to Final Office Action mailed Feb. 17, 2012”, 19 pgs.
“U.S. Appl. No. 12/045,416, Response filed Dec. 5, 2011 to Non Final Office Action mailed Aug. 4, 2011”, 18 pgs.
“U.S. Appl. No. 12/045,416, Restriction Requirement mailed May 11, 2011”, 8 pgs.
“U.S. Appl. No. 12/196,831, Advisory Action mailed Jan. 21, 2011”, 3 pgs.
“U.S. Appl. No. 12/196,831, Advisory Action mailed Jul. 5, 2012”, 3 pgs.
“U.S. Appl. No. 12/196,831, Examiner Interview Summary mailed Feb. 6, 2012”, 18 pgs.
“U.S. Appl. No. 12/196,831, Final Office Action mailed Apr. 12, 2012”, 17 pgs.
“U.S. Appl. No. 12/196,831, Final Office Action mailed Nov. 12, 2010”, 9 pgs.
“U.S. Appl. No. 12/196,831, Non Final Office Action mailed Jul. 9, 2010”, 7 pgs.
“U.S. Appl. No. 12/196,831, Non Final Office Action mailed Oct. 6, 2011”, 8 pgs.
“U.S. Appl. No. 12/196,831, Response filed Jan. 10, 2011 to Final Office Action mailed Nov. 12, 2010”, 10 pgs.
“U.S. Appl. No. 12/196,831, Response filed Feb. 1, 2012 to Non Final Office Action mailed Oct. 6, 2011”, 15 pgs.
“U.S. Appl. No. 12/196,831, Response filed Jun. 12, 2012 to Final Office Action mailed Apr. 12, 2012”, 14 pgs.
“U.S. Appl. No. 12/196,831, Response filed Jun. 21, 2010 to Restriction Requirement mailed Jun. 8, 2010”, 8 pgs.
“U.S. Appl. No. 12/196,831, Response filed Sep. 12, 2012 to Advisory Action mailed Jul. 5, 2012”, 16 pgs.
“U.S. Appl. No. 12/196,831, Response filed Oct. 7, 2010 to Non Final Office Action mailed Jul. 9, 2010”, 11 pgs.
“U.S. Appl. No. 12/196,831, Restriction Requirement mailed Jun. 8, 2010”, 7 pgs.
“U.S. Appl. No. 12/873,030, Non Final Office Action mailed Oct. 30, 2012”, 17 pgs.
“U.S. Appl. No. 12/873,030, Response filed Feb. 28, 2013 to Non Final Office Action mailed Oct. 30, 2012”, 14 pgs.
“U.S. Appl. No. 12/873,030, Response filed Jul. 27, 2012 to Restriction Requirement mailed Jul. 10, 2012”, 7 pgs.
“U.S. Appl. No. 12/873,030, Restriction Requirement mailed Jul. 10, 2012”, 6 pgs.
“U.S. Appl. No. 12/873,049, Notice of Allowance mailed Mar. 25, 2013”, 9 pgs.
“U.S. Appl. No. 12/873,049, Notice of Allowance mailed Nov. 14, 2012”, 13 pgs.
“U.S. Appl. No. 12/873,049, Response filed Jul. 27, 2012 to Restriction Requirement mailed Jul. 10, 2012”, 8 pgs.
“U.S. Appl. No. 12/873,049, Restriction Requirement mailed Jul. 10, 2012”, 5 pgs.
“Aseptically-Processed Bone and Connective Tissue”, American Red Cross, (1995), 2 pgs.
“Australian Application Serial No. 200116857, Office Action mailed Feb. 13, 2004”, 2 pgs.
“Canadian Application Serial No. 00979315.9, Office Action mailed Jan. 24, 2007”, 3 pgs.
“Canadian Application Serial No. 00979315.9, Response filed Jul. 23, 2007 to Office Action mailed Jan. 24, 2007”, 14 pgs.
“Disinfectant Details and Their Uses”, The Master Budgerigar Breeder <http://www.bestofbreeds.net/masterbreeder/chap6/chap6disinfectant6.htm>, (1991), 1-14.
“European Application Serial No. 04020622.9, European Search Report mailed Nov. 29, 2004”, 6 pgs.
“European Application Serial No. 04020622.9, Office Action mailed Oct. 20, 2005”, 3 pgs.
“European Application Serial No. 04020622.9, Response filed Apr. 13, 2006 to Office Action mailed Oct. 20, 2005”, 12 pgs.
“High Pressure Process”, (1991), 1-14.
“International Application Serial No. PCT/CH2000/000659, International Preliminary Examination Report mailed Mar. 20, 2002”, 15 pgs.
“International Application Serial No. PCT/CH2000/000659, International Search Report mailed Jan. 2, 2001”, 8 pgs.
“International Application Serial No. PCT/US2008/063582, International Preliminary Report on Patentability mailed Nov. 24, 2009”, 8 pgs.
“International Application Serial No. PCT/US2008/063582, International Search Report mailed Oct. 9, 2008”, 3 pgs.
“International Application Serial No. PCT/US2008/063582, Written Opinion mailed Oct. 9, 2008”, 7 pgs.
“International Application Serial No. PCT/US2008/064653, International Search Report mailed Sep. 7, 2009”, 3 pgs.
“International Application Serial No. PCT/US2008/064653, Written Opinion mailed Sep. 7, 2009”, 8 pgs.
“International Application Serial No. PCT/US2009/036661, International Preliminary Report on Patentability mailed Sep. 14, 2010”, 9 pgs.
“International Application Serial No. PCT/US2009/036661, International Search Report mailed Jun. 12, 2009”, 4 pgs.
“International Application Serial No. PCT/US2009/036661, Written Opinion mailed Jun. 12, 2009”, 8 pgs.
“Japanese Application Serial No. 2000-544609, Office Action mailed Jan. 5, 2010”, 9 pgs.
“Japanese Application Serial No. 2000-544609, Office Action mailed Mar. 24, 2009”, 8 pgs.
“Japanese Application Serial No. 2000-544609, Office Action mailed Aug. 5, 2008”, 5 pgs.
“Japanese Application Serial No. 2000-544609, Office Action mailed Nov. 2, 2010”, 7 pgs.
“Japanese Application Serial No. 2000-544609, Response filed Apr. 27, 2010 to Office Action mailed Jan. 24, 2010”, 8 pgs.
“Japanese Application Serial No. 2000-544609, Response filed Jun. 11, 2009 to Office Action mailed Mar. 24, 2009”, 14 pgs.
“Japanese Application Serial No. 2000-544609, Response filed Oct. 28, 2008 to Office Action mailed Aug. 5, 2008”, 14 pgs.
“Macro Sensors”, LVDT Basics, Technical Bulletin 0103, (Jan. 31, 2003), 4.
“Omnicide 14 Day Glutaraldehyde Disinfectant Gallon”, (Accessed Mar. 6, 2008), 1-2.
“Omnicide—The DEFRA approved disinfectant to kill Avian Influenza”, The Coventry Group, (2007), 1-2.
“Resorbable, Cylindrical Scaffold to Support Healing of Tissue”, TruFit BGS Plugs, Bone Graft Substitute Plugs, Publication # 6100048, OsteoBiologics, Inc. San Antonio, TX USA, (2004), 2 pgs.
“Single Use OATS (Osteochondral Autograft Transfer System) Surgical Technique”, Arthrex, Inc., Naples, FL, USA, (2005), 6 pgs.
“Standards for Tissue Banking”, American Association of Tissue Banks, 12th Edition, (2008), 21 pgs.
“Trough”, Merriam-Websters Dictionary Definition, http://www.merriam-webster.com/dictionary/trough, (Nov. 2010), 3 pgs.
Aichroth, et al., “Biologicl and Mechanical Problems of Osteoarticular Allografting: The Relation to Clinical Organ Transplantation”, The Journal of the Western Pacific Orthopaedic Association, vol. VIII, No. 2, London England, No Image Available, (1971), 25-70.
Akens, “In-viro and in-vivo studies of osteochondral transplants pretreated with photo-oxidation”, Ph.D. Thesis, (2002), 1-100.
Akens, Margarete K, et al., “Long term in-vivo studies of a photo-oxidized bovine osteochondral transplant in sheep.”, BMC Musculoskeletal Disorders, vol. 2, No. 9, (2001), 12 pgs.
Albee, Fred H, “Bone Surgery With Machine Tools”, Scientific American vol. 154.4, (Apr. 1936), 178-181.
Bakay, et al., “A mushroom-shaped osteochondral patella allograft”, International Orthopaedics (SICOT) 20, (1996), 370-372.
Bakay, et al., “Osteochondral resurfacing of the knee joint with allograft”, International Orthopaedics (SICOT) 22, (1998), 277-281.
Bakay, et al., “The alternatives of the application of human lyophillized spongiosa and bone-matrix gelatin”, Orvosi Hetilap, vol. 136, No. 35, Budpest, (1995), 1891-1896.
Baragi, et al., “Transplantation of adenvirally transduced allogeneic chondrocytes into articular cartilage defects in vivo”, Osteoarthritis and cartilage, vol. 5, (1997), 275-282.
Barber, et al., “COR Osteochondral Repair System”, Osteobiologics, Inc., (2006), 17 pgs.
Barber, et al., “Osteochondral Repair System”, www.obi.com, (2006), 1-17.
Barber, F. Alan, “An Arthroscopic Technique for Repair of Osteochondral Defects”, The New Generation in Osteochondral Transplantation, DePuy Mitek, Inc., Raynham, MA USA, (2007), 9 pgs.
Barber, F. Alan, et al., “Osteochondral Repair System”, <www.obi.eomlproducts—TruFit.htm>, 17 pgs, Sep. 11, 2006.
Bar-Shavit, Z., et al., “Glucocorticoids Modulate Macrophage Surface Oligo saccharides and Their Bone Binding Activity”, J. Clin. Invest., vol. 73, (1984), 1277-1283.
Beaver, R. J, et al., “Fresh Osteochondral Allografts for Post-Traumatic Defects in the Knee”, The Journal of Bone and Joint Surgery, vol. 74-8, No. 1, (1992), 105-110.
Bobic, V, “Arthroscopic osteochondral autograft transplantation in anterior cruciate ligament reconstruction: a preliminary clinical study”, Knee Surg, Sport Traumatol, Arthroscopy 3, (1996), 262-264.
Bodo, G., et al., “Arthroscopic Autologous Osteochondral Mosaicplasty for the Treatment of Subchondral Cystic Lesion in the Medial Femoral Condyle in a Horse”, Acta Veternaria Hungarica, vol. 48(3), (2000), 343-354.
Bos, et al., “Immune Responses of Rats to Frozen Bone Allografts”, The Journal of Bone and Joint Surgery 65A(2), (1983), 239-246.
Brighton, et al., “Articular Cartilage Preservation and Storage”, Arthritis and Rheumatism 22(10), (1979), 1093-1101.
Brooks, et al., “Immunological Factors in Homogenous Bone Transplantation”, The Journal of None and Joint Surgery 45(8), (1963), 1617-1626.
Bugbee, “Fresh Osteochondral Allografts”, The Journal of Knee Surgery 15(3), (2002), 191-195.
Bugbee, et al., “Osteochondral Allograft Transplantation”, Complex Topics in Knee Surgery, vol. 18, No. 1, (1999), 67-75.
Bugbee, William D, “Fresh Osteochondral Allografts”, Seminars in Arthroplasty, vol. 11, No. 4, No Image Available, (2000), 221-226.
Burba, et al., “An arthroscopic biopsy procedure for obtaining osteochondral samples from the equine midcarpal joint”, Journal of Investigative Surgery, vol. 5, (1992), 343-359.
Calandruccio, et al., “Proliferation, Regeneration, and Repair of Articular Cartilage of Immature Animals”, J. Bone Joint Surg, vol. 44-A, No. 3, (1962), 431-455.
Chalmers, J, “Transplantation immunity in bone homografting”, The Journal of Bone and Joint Surgery, vol. 41B, No. 1, No Image Available, (1959), 160-179.
Chu, et al., “Articular Cartilage Transplantation—Clinical Results in the Knee”, Clinical Orthoaedics and Related Research, (1991), 139-145.
Clarke, Ian C, “Quantitative measurement of human articular surface topography in vitro by profile recorder and stereomicroscopy techniques”, Journal of Microscopy, vol. 97, Pl. 3, (Apr. 1973), 309-314.
Convery, et al., “Fresh osteochondral allografting of the femoral condyle”, Clinical Orthopaedics and Related Research No. 273, (1991), 139-145.
Convery, et al., “Long-Term Survival of Chondrocytes in an Osteochondral Articular Cartilage Allograft”, A Case Report 78(7), (1996), 1082-1087.
Convery, F.R., et al., “The Repair of Large Osteochondral Defects”, An Experimental Study in Horses, Clin. Orthrop. 82., (1972), 253-262.
Cornell, et al., “A biosensor that uses ion-channel switches”, Nature vol. 387, (Jun. 1997), 580-583.
Csonge, Lajos, et al., “Banking of Osteochodral allografts. Part I. Viability assays adapted for osteochondral and cartilage studies”, Cell and Tissue Banking 3, (2002), 151-159.
Csonge, Lajos, et al., “Banking of Osteochondral Allografts, Part II. Preservation of Chondrocyte Viability During Long-Term Storage”, Cell and Tissue Banking 3, (2002), 161-168.
Czitrom, et al., “Bone and Cartilage Allotransplantation: Review of 14 Years of Research and Clinical Studies”, Clinical Orthopedics and Related Research, (1986), 141-145.
Delloye, et al., “Osteochondral Allografts in Arm and Forearm Surgery”, Acta Orthopaedica Belgica, vol. 57, (1991), 75-83.
Desjardins, et al., “Incorporation of Fresh and Cryopreserved Bone in Osteochondral Autografts in the Horse”, Veterinary Surgery, vol. 20, No. 6, (1991), 446-452.
Donald, Paul J, “Cartilage Grafting in Facial Reconstructions with Special Consideration of Irradiated Grafts”, Laryngoscope, vol. 96, (1986), 786-806.
Ehalt, W, “Bisherige Erfahrungen mit dem plastischen Ersatz von Gelenkknorpel aus der Knochenbank”, Verh. Dtsch. Orthop. Ges. 43, (1955), 107-109.
Ehalt, W., et al., “Gelenkknorpel-Plastik”, Langenbecks Arch. Kiln. Chir. 299, (1962), 768-774.
Ehalt, Walther M, “Grafting of joint-cartilage Bone-Blocks from the bank”, VI. Congr. Soc. Internat. Chir. Orthop. Traumatol. S., (1954), 419-421.
Elves, et al., “A Study of the Humoral Immune Response to Osteoarticular Allografts in the Sheep”, Clin. exp. Immunol., vol. 17, (1974), 497-508.
Flynn, et al., “Osteoarticular Allografts to Treat Distal Femoral Osteonecrosis”, Clin. Orthop. Rel. Res., No. 303, (1994), 38-43.
Friedlaender, et al., “Studies on the antigenicity of bone. I. Freeze-dried and deep-frozen bone allografts in rabbits”, The Journal of Bone & Joint Surgery, vol. 58, (1976), 854-858.
Friedlaender, Gary E, “Immune Responses to Osteochondral Allografts”, Clinical Orthopaedics and Related Research, No. 174, (1983), 58-68.
Garrett, John C, “Fresh Osteochondral Allografts for Treatment of Articular Defects in Osteochondritis Dissecans of the Lateral Femoral Condyle in Adults”, Clinical Orthopaedics and Related Research, 303, (1994), 33-37.
Garrett, John C, “Osteochondral Allografts”, Instructional Course Lectures, vol. 42, (1993), 355-358.
Garrett, John C, “Osteochondral Allografts for Reconstruction of Articular Defects of the Knee”, AAOS Instructional Course Lectures, 27, (1998), 517-522.
Garrett, John C, “Treatment of Osteochondral Defects of the Distal Femur with Fresh Osteochondral Allografts: A Preliminary Report”, Arthroscopy: The Journal of Arthroscopic and Related Surgery 2(4), (1986), 222-226.
Ghazavi, M. T, et al., “Fresh Osteochondral Allografts for Post-Traumatic Osteochondral Defects of the Knee”, J. Bone Joint Surg., 79-B, (1997), 1008-1013.
Gould, Nathaniel, “Trephining Your Way”, Orthopedic Clinics of North America, vol. 4, No. 1, (1973), 157-164.
Gross, “Use of Fresh Osteochondral Allografts to Replace Traumatic Joint Defects”, Allografts in Orthopaedic Practice Ch 5, (1992), 67-82.
Guhl, James F, “Chapter 21: The Impact of Arthroscopy on Osteochondritis Dissecans”, Operative Arthroscopy, (1991), 297-317.
Hangody, L, et al., “Autogenous osteochondral grafting in the knees of German Shepherd dogs: Radiographic and histological analysis”, Hungarian Review of Sports Medicine 35, (1994), 117-123.
Hangody, L, et al., “Treatment of localized chondral and osteochondral defects in the knee by a new autogenous osteochondral grafting tenique”, Hungarian Review of Sports Medicine 35, (1994), 241-246.
Hangody, Laszlo, “Arthroscopic autogeous osteochondral mosaicplasty for the treatment of femoral condylar articular defects: A preliminary report”, Knee Surg, Sports Traumatol, Arthrosc 5, (1997), 262-267.
Hangody, Laszlo, et al., “Artoszkopos autolog osteochondralis mozaikplastica (Arthroscopic autogenous osteochondral mosaicplasty)”, Hungarian Journal of Traumatology and Orthopaedics 39, (1996), 49-54.
Hangody, Laszlo, et al., “Autogenous Osteochondral Graft Technique for Replacing Knee Cartilage Defects in Dogs”, Autogenous Osteochondral Mosaicplasty—Orthopaedics International Ed., vol. 5, No. 3, (1997), 175-181.
Hangody, Laszlo, “Autologous osteochondral mosaic-like graft technique for replacing weight bearing cartilage defects”, 7th Congress of ESSTKSA, Abstract Only, (1996), 3 pgs.
Hangody, Laszlo, et al., “Autologous Osteochondral Mosaic-Plasty”, Review of Osteology 3, (1996), 70-73.
Hangody, Laszlo, “Chapter 13: Autogenous Osteochondral Mosaicplasty for the Treatment of Focal Chondral and Osteochondral Defects of the Femoral Condyles”, Knieinstabilitat und Knorpelschaden, (1998), 97-106.
Hangody, Laszlo, “Mosaic-plasty in Clinical Practice”, Review of Osteology 4, (1996), 32-36.
Hangody, Laszlo, et al., “Mosaicplasty for the Treatment of Articular Cartilage Defects: Application in Clinical Practice”, Orthopedics 21(7), (1998), 751-756.
Hangody, Laszlo, et al., “Mosaicplasty for the treatment of osteochondritis dissecans of the knee”, [Online]. Retrieved from the Internet: <URL: http://www.egydoc.com/Sites/Arthroclub/AC—Files/Articles/article39.pdf>, (Accessed Nov. 8, 2005), 9 pgs.
Hangody, Laszlo, et al., “New Method in Treatment of Sever Local Cartilage Damage in the Knee Joint (Eine neue Methode in der Behandlung von schweren, lokalen Knorpelschaden im Kniegelenk”, Osteosynthese International 5, (1997), 316-321.
Hangody, Laszlo, et al., “Osteochondral Grafting Using the Smith & Nephew Mosaicplasty System”, Mosiacplasty Autogenous Osteochondral Grafting System, Knee Series, Technique Guide, (2001, 2005), 12 pgs.
Hangody, Laszlo, et al., “Osteochondral Plugs: Autogenous Osteochondral Mosaicplasty for the Treatment of Focal Chondral and Osteochondral Articular Defects”, Operative Techniques in Orthopaedics 7(4), (1997), 312-322.
Hangody, Laszlo, et al., “Sülyos, körülírt térdízületi porckárosodás sebészi kezelésének új lehetosége (New alternative in the treatment of sever, localized cartilage damages in the knee joint)”, Hungarian Journal of Traumatology and Orthopaedics 37, (1994), 237-242.
Hangody, Laszlo, et al., “Treatment of Osteochondritis Dissecans of the Talus: Use of Mosaicplasty Technique—A Preliminary Report”, Foot and Ankle International 18(10), (1997), 628-634.
Harrison, et al., “Effect of Extraction Protocols and Epidermal Growth Factor on the Cellular Repopulation of Decellularized Anterior Cruciate Ligament Allografts”, Wiley Periodicals, Inc. J. Biomed Mater Res 75A, (2005), 841-854.
Hetherington, Vincent J, et al., “Immunologic Testing for Xeno-Derived Osteocartilagenous Grafts”, Ohio College of Podiatric Medicine Research Foundation, (2002), 1 pg.
Hetherington, Vincent J, et al., “Immunologic Testing of xeno-derived osteochondral grafts using peripheral blood mononuclear cells from healthy human donors”, BMC Musculoskeletal Disorders vol. 6, No. 36, (2005), 11 pgs.
Hetherington, Vincent J, et al., “Qualitative Histological Evaluation of Photooxidized Bovine Ostechondral Grafts in Rabbits: A Pilot Study”, The Journal of Foot & Ankle Surgery, vol. 46(4), (2007), 223-229.
Hudson, et al., “OptimizedAcellular Nerve Graft is Immunologically Tolerated and Supports Regeneration”, Tissue Engineering 10(11/12), (2004), 1641-1652.
Hurtig, et al., “Osteochondral Dowel Transplantation for Repair of Focal Defects in the Knee: an Outcome Study Using an Ovine Model”, Vet. Surgery vol. 27, (1998), 5-16.
Hurtig, M B, “Experimental use of small osteochondral grafts for resurfacing the equine third carpal bone”, Equine Orthopaedics, Supp. 6, (1988), 23-27.
Hurtig, M, et al., “Surgical and analytical techniques for articular cartilage transplantation”, Veterinary Surgery, The Official Journal of the American College of Veterinary Surgeons, Inc., vol. 21, No. 5, (1992), 394.
Hurtig, M, et al., “Surgical and analytical techniques for assessment of transplanted articular cartilage: A pilot study”, Cryobiology, 29(6), Twenty-ninth Annual Meeting of the Society for Cryobiology Ithaca, New York, USA, (1992), 732.
Jakob, et al., “Autologous Osteochondral Grafting in the Knee: Indication, Results and Reflections”, Clinical Orthopaedics and Related Research, No. 401, (2002), 170-184.
Jakob, et al., “Isolated articular cartilage lesion: repari or regeneration”, Osteoarthritis and Cartilage Journal of the OsteoArthritis Research Society International, vol. 9, Supplement A, www.idealibrary.com, (2001), S3-S5.
Jamali, et al., “Donor cell survival in a fresh osteochondral allograft at twenty-nine years”, The Journal of Bone & Joint Surgery, vol. 89, (2007), 166-169.
Jimenez, et al., “Experimental Studies on the Fate of Transplanted Articular Cartilage”, Osteochondral Allografts, Biology, Banking and Clinical Applications, (1983), 73-79.
Kamijou, et al., “Effects of Osteocytes on Osteoinduction in the Autogenous Rib Graft in the Rat Mandible”, Bone, vol. 15, No. 6, (1994), 629-637.
Kawalec-Carroll, et al., “Immunogenicity of unprocessed and photooxidized bovine and human osetochondral grafts in collagen-sensitive mice”, BMC Musculo. Dis., vol. 7, (2006), 1471-2474.
Kawamura, et al., “Human Fibrin Is a Physiologic Delivery System for Bone Morphogenetic Protein”, Clinical Orthopaedics and Related Research, (Oct. 1988), 302-310.
Kelley, et al., “Chondrocyte repopulation of allograft cartilage: A preliminary investigation and strategy for developing cartilage matrice for reconstruction”, Otolaryngology-Head and Neck Surgery, vol. 127, No. 4, (2002), 265-270.
Kluger, et al., “Removal of the surface layers of human cortical bone allografts restores in vitro osteoclast function reduced by processing and frozen storage”, Bone 32, (2003), 291-296.
Kubler, N., et al., “Bone Morphogenetic Protein-Mediated Interaction of Periosteum and Diaphysis”, Clincal Orthopedics and Related Research, vol. 258, (1990), 279-294.
Kwan, et al., “Histological and Biomechanical Assessment of Articular Cartilage from Stored Osteochondrol Shell Allografts”, Journal of Orthopaedic Research, vol. 7, No. 5, (1989), 637-644.
Lehman, Richard C, “Surgical Technique for Backfill of Graft Harvest Site for Osteochondral Autograft Transfer (OATS) Procedure”, Osseofit Porous Tissue Matrix, BIOMET Sports Medicine, Inc., Warsaw, IN USA, (2008), 12 pgs.
Lexer, E, “Joint transplantation”, Clinical Orthopaedics and Related Research, No. 197, (1985), 4-10.
Lindholm, Sam, et al., “Reconstruction of the Articular Surface by Transfixation of an Osteochondral Fragment of the Femoral Condyle Using a Bone Transplant”, Scandinavian Journal of Rheumatology Supplement 44, (1982), 5-13.
Locht, et al., “Late Osteochondral Allograft Resurfacing for Tibial Plateau Fractures”, The Journal of Bone and Joint Surgery 66(3), (1984), 328-335.
Mahomed, M.N., et al., “The Long-Term Success of Fresh, Small Fragment Osteochondral Alografts Used for Intraarticular Post-Traumatic Defects in the Knee Joint”, Orthopedics 15, (1992), 1191-1199.
Malinin, et al., “Banking of Massive Osteoarticular and Intercalary Bone Allografts—12 Years Experience”, Clinical Orthopaedics and Related Research, No. 197, (1985), 44-57.
Malinin, et al., “Cryopreservation of articular cartilage”, Clinical Orthopaedics and Related Research, No. 33, (1994), 18-32.
Mankin, et al., “Clinical experience with allograft implantation”, Clinical Orthopaedics and Related Research, No. 74, (1983), 69-86.
Marco, F, et al., “Osteochondral Allografts in Femoral Condyles”, International Orthopaedics 17, (1993), 105-108.
Matsusue, et al., “Arthroscopic Multiple Osteochondral Transplantation to the Chondral Defect in teh Knee Associated with Anterior Cruciate Ligament Disruption”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 9, No. 3, (1993), 318-321.
Maury, et al., “Twenty-five year chondrocyte viability in fresh osteochondral allograft. A Case Report”, The Journal of Bone & Joint Surgery, vol. 89, (1993), 159-165.
McDermott, et al., “Fresh small-fragment osteochondral allografts”, Clinical Orthopaedics and Related Research, No. 197, (1985), 96-102.
McPherson, et al., “Creep Behavior of Osteochondral Grafts in Sheep”, 39th Annual Meeting, Orthopaedic Research Society, (1993), 227.
Meyers, et al., “Resurfacing of the Femoral Head with Fresh Osteochondral Allograft”, Clinical Orthopaedics adn Related Research, No. 197, (1985), 111-114.
Meyers, et al., “Resurfacing of the Knee with Fresh Osteochondral Allograft”, J. Bone Joint Surg., (1989), 704-713.
Muller, W, “Osteochondrosis Dissecans”, Progress in Orthopaedic Surgery vol. 3, (1978), 135-142.
Oakeshott, et al., “A Clinical and Histological Analysis of Failed Fresh Osteochondral Allogafts”, Clinical Orthopaedics and Related Research, No. 233, (1988), 283-294.
Outerbridge, R E, “Joint Surface transplants—a preliminary report”, The Journal of Western Pacific Orthopaedic Association, vol. VIII, No. 1, (1971), 1-15.
Pap, et al., “Arthroplasty of the Knee: Experimental and Clinical Experiences”, The Journal of Bone& Joint Surgery, vol. 43-A, No. 4, (1961), 523-537.
Pegg, et al., “Cryopreservation of articular cartilage. Part 1: Conventional cryopreservation methods”, Cryobiology 52, (2006), 335-346.
Peretti, Giuseppe M, et al., “Bonding of cartilage matrices with cultured chondrocytes: an experimental model”, Journal of Orthopaedic Research 16(1), (1998), 89-95.
Pollok, et al., “Long term insulin-secretory function of islets of Langerhans encapsulated with a layer of confluent chondrocytes for immunoisolation”, Pediatric Surg Int, vol. 15, (1999), 164-167.
Pollok, J. M., et al., “Immunoisolation of xenogeneic islets using a living tissue engineered cartilage barrier”, Transplantation Proceedings, 29(4), (1997), 2131-2133.
Rechenberg, et al., “Changes in subchondral bone in cartilage resurfacing—an experimental study in sheep using different types of osteochondral grafts”, OsteoArthritis and Cartilage, vol. 11, (2003), 265-277.
Robert, et al., “Studies on the Nature of the “Microfibrillar” Component of Elastic Fibers”, Eur. J. Biochem. 21, (1971), 507-516.
Rodrigo, et al., “Osteocartilaginous Allografts as Compared with Autografts in teh Treatment of Knee Joint Osteocartilaginous Defects in Dogs”, Clinical Orthopaedics and Related Research, No. 134, (1978), 342-349.
Roffman, Moshe, “Autogenou grafting for an osteochondral fracture of the femorale condyle”, Acta Orthop Scand., vol. 66, No. 6, (1995), 571-572.
Ronsky, J L, et al., “Precise Measurement of Cat Patellofemoral Joint Surface Geometry with Multistation Digital Photogrammetry”, Journal of Biomechanical Engineering, vol. 121, (Apr. 1999), 196-205.
Scbachar, et al., “Transplantation of cryopreserved osteochondral dowel allografts of focal articular defects in Ovine model”, J. Orthop.Res., 17(6), (1999), 909-919.
Schachar, et al., “The effect of Cryopreservative Agents on teh Viability of Frozen Human Articular Cartilage”, Canadian Orthopaedic Research Society, (1978), 79-80.
Scharchar, et al., “Fate of massive osteochondral allografts in a feline model”, Osteochondral Allografts, Biology, Banking, and Clinical Applications, (1983), 81-101.
Scharchar, et al., “Metabolic and biochemical status of articular cartilage following cryopreservation and transplantation: a rabbit model”, Journal of Orthopaedic Research, vol. 10, (1992), 603-609.
Shahgaldi, B F, et al., “Repair of Cartilage Lesions Using Biological Implants—A Comparative Histological and Biomechanical Study in Goats”, Journal of Bone & Joint Surgery, vol. 73-5, UK, (1991), 57-64.
Shimizu, et al., “Bone resorption by isolated osteoclasts in living versus devitalized bone”, Journal of Bone and Mineral Research, vol. 5, No. 4, (1990), 411-418.
Stevenson, et al., “The Fate of Articular Cartilage after Transplantation of Fresh and Cryopreserved Rissue-Antigen-Matched and Mismatched Osteochondral Allografts in Dogs”, J. Bone Joint Surg. vol. 71-A, No. 9, (1989), 1297-1307.
Stone, et al., “Meniscal regeneration with copolymeric collagen scaffolds”, Amer. J. Sports Med., col. 20, No. 2, (1992), 104-111.
Stone, et al., “Porcine Cartilage Transplants in the Cynomolgus Monkey: III. Transplantation of a-Galactosidase-Treated Porcine Cartilage”, Transplantation, vol. 65, No. 12, (1998), 1577-1583.
Stone, et al., “Replacement of Human Anterior Cruciate Ligaments with Pig Ligaments: A Model for Ani-Non-Gal Antibody Response in Long-Term Exenotransplantation”, Transplantation, vol. 83, No. 2, (2007), 211-219.
Toolan, et al., “Development of a Novel Osteochondral Graft for Cartilage Repair”, John Wiley & Sons, Inc. J.Biomed Mater Res, 41, (1998), 244-250.
Verbruggen, et al., “Repair Function in Organ Cultured Human Cartilage. Replacement of Enzymatically Removed Proteoglycans During Longterm Organ Culture”, The Journal of Rheumatology 12(4), (1985), 665-674.
Volkov, et al., “Use of Allogenous Articular Bone Implants as Substitutes for Autotransplants in Adult Patients”, Clinical Orthopaedics and Related Research, No. 114, (1976), 192-202.
Von Rechenberg, et al., “Changes in subchondral bone in cartilage resurfacing—an experimental study in sheep using different types of osteochondral grafts”, Osteoarthr. Cart., vol. 11, (2003), 265-277.
Von Rechenberg, et al., “Mosaicplasty with photooxidized, mushroom-shaped, bovine, ostechondral xenografts in experimental sheep”, Vet. Comp. Orthop. Traumatol., vol. 3, (2006), 147-156.
Von Rechenberg, et al., “The use of photooxidixed, mushroom-shaped osteochondral grafts for cartilage resurfacing—a comparison to photooxidized cylindrical grafts in an experimental study in sheep”, Osteoarthr. Cart., vol. 12, (2004), 201-216.
Wada, Yuichi, “Architectural remodeling in deep frozen meniscal allografts after total meniscectomy”, Arthroscopy: The Journal of Arthoscopic and Related Surgery, vol. 14, No. 3, (1998), 250-257.
Wohl, G, et al., “Assessment of Bone Mechanical Integrity in Osteochondral Grafts”, Orthopaedic Research Society, (1994), p. 526.
Woods, et al., “Effectiveness of three extraction techniques in the development of a decellularized bone-anterior cruciate ligament-bone graft”, Biomaterials, Elsevier Science Publishers, vol. 26, No. 35, (Dec. 1, 2005), 7339-7349.
Yamashita, F., et al., “The Transplantatoin of Autogeneic Osteochondral Fragment for Osteochondritis Dissecans of the Knee”, Orthopedics 15, (1992), 1191-1199.
“U.S. Appl. No. 10/149,853, Preliminary Amendment filed Sep. 14, 2012”, 7 pgs.
“U.S. Appl. No. 12/196,831, Examiner Interview Summary mailed Nov. 25, 2013”, 3 pgs.
“U.S. Appl. No. 12/196,831, Non Final Office Action mailed Oct. 3, 2013”, 21 pgs.
“U.S. Appl. No. 12/196,831, Response filed Nov. 27, 2013 to Non-Final Office Action dated Oct. 3, 2013”, 13 pgs.
“U.S. Appl. No. 12/873,030, Advisory Action mailed Oct. 16, 2013”, 3 pgs.
“U.S. Appl. No. 12/873,030, Final Office Action mailed Aug. 1, 2013”, 14 pgs.
“U.S. Appl. No. 12/873,030, Non Final Office Action mailed Nov. 6, 2013”, 11 pgs.
“U.S. Appl. No. 12/873,030, Response filed Oct. 1, 2013 to Final Office Action mailed Aug. 1, 2013”, 15 pgs.
“U.S. Appl. No. 13/619,022, Non Final Office Action mailed May 8, 2013”, 6 pgs.
U.S. Appl. No. 11/753,102, Non Final Office Action mailed Feb. 26, 2014, 9 pgs.
U.S. Appl. No. 12/196,831, Final Office Action mailed Jan. 30, 2014, 19 pgs.
U.S. Appl. No. 12/873,030, Response filed Mar. 6, 2014 to Non-Final Office Action dated Nov. 6, 2013, 15 pgs.
Related Publications (1)
Number Date Country
20130231745 A1 Sep 2013 US
Continuations (1)
Number Date Country
Parent 12873049 Aug 2010 US
Child 13855157 US